Back to search

Article

Patient Perspectives on Buprenorphine Treatment for Opioid Use Disorder and Preferences for Long-Acting Injectable Formulations: Findings from a National Online Survey

2026-02-06

Abstract excerpt

<h4>Background</h4> Long-acting injectable buprenorphine (LAIB) has been positioned as a potentially transformative option for opioid use disorder (OUD), in part because patient experiences reported in qualitative studies emphasize reduced daily burden, increased “freedom,” reduced stigma, and fewer pressures related to diversion—while also noting barriers such as insufficient information, early adverse experienc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ca9a7dfd-edc5-5690-9818-b32f8079adda
DOI
10.64898/2026.02.05.26345663
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Patient Perspectives on Buprenorphine Treatment for Opioid Use Disorder and Preferences for Long-Acting Injectable Formulations: Findings from a National Online SurveyDOI 10.64898/2026.02.05.26345663
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: A cross-sectional survey of provider experiencesSemantic proximity
Experiences of Opioid Use and Perceptions of Medication-Assisted Treatment (MAT) in Oakland's Safety Net Clinics Amid the COVID-19 PandemicSemantic proximity
Buprenorphine treatment of opioid dependence: analysis of individual patient dataSemantic proximity
Shared decision making and client-reported dose satisfaction in a longitudinal cohort receiving iOATSemantic proximity
How should low-threshold and primary care clinics prepare to provide long-acting injectable buprenorphine? A qualitative implementation study of patient and staff perspectivesSemantic proximity
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: Protocol for an open-label, parallel-group, superiority, randomized controlled trialSemantic proximity
“The idea is to help people achieve greater success and liberty”: a qualitative study of expanded methadone take-home access in opioid use disorder treatmentSemantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Exploring Opioid Management Challenges in Chronic Non-Tumor Pain: Findings from a Mixed-Methods Study among General PractitionersSemantic proximity
Exploring real-world user experiences of GLP-1 receptor agonist therapy for obesity treatment, and barriers and motivators to adherenceSemantic proximity
Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.Semantic proximity
Select a neighboring publication to make it the new centre.